SEC Form 4 · accession 0001144204-17-001694
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Mehren
Officer — PRESIDENT AND CEO · Director
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 7:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 9, 2017 | S | 400,068 | $19.00 | D | 615,289 | D | |
| Common Stock | Jan 9, 2017 | X | 370,307 | $2.00 | A | 985,596 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F2 | $2.00 | Jan 9, 2017 | X | 370,307 | D | Jun 26, 2012 | Jun 26, 2017 | Common Stock | 370,307 | 0 | D |
Explanation of responses
- F1Includes shares previously held through MAB, LLC, which were distributed to the reporting person on a pro rata basis according to his membership interest therein and are now owned directly.
- F2Includes warrants previously held through MAB, LLC, which were distributed to the reporting person and are now owned directly.